Sarepta Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $1.6M | $247.2M | $257.0M |
| FY2014 | $1.5M | $247.7M | $73.6M |
| FY2015 | $26.8M | $190.3M | $80.3M |
| FY2016 | $17.7M | $336.7M | $122.4M |
| FY2017 | $431.1M | $789.2M | $599.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $1.6M | $247.2M | $257.0M |
| FY2014 | $1.5M | $247.7M | $73.6M |
| FY2015 | $26.8M | $190.3M | $80.3M |
| FY2016 | $17.7M | $336.7M | $122.4M |
| FY2017 | $431.1M | $789.2M | $599.7M |